Investors race to cover 'quality' Medacta IPO

Medacta, a manufacturer of orthopaedic devices, was covered within hours of setting the terms on its Swiss IPO, valuing the company at up to Sfr2.08bn.

  • By Sam Kerr
  • 22 Mar 2019

Credit Suisse and Morgan Stanley are global coordinators, while JP Morgan and UBS bookrunners.

The IPO consists of an all-secondary share sale by the family of Alberto Siccardi, who founded the company in 1999 and remains its chairman. Francesco Siccardi is the CEO.

Medacta’s main offerings are hip and knee joints but ...

Please take a trial or subscribe to access this content.

Contact our subscriptions team to discuss your access: subs@globalcapital.com

Corporate access

To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: subs@globalcapital.com or find out more online here.

All International Bonds

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • Today
1 JPMorgan 135,414.03 562 8.27%
2 Citi 128,055.36 503 7.82%
3 Bank of America Merrill Lynch 106,567.48 424 6.50%
4 Barclays 102,724.49 401 6.27%
5 Deutsche Bank 83,239.76 333 5.08%

Bookrunners of All Syndicated Loans EMEA

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • Today
1 Bank of America Merrill Lynch 11,525.35 30 6.99%
2 UniCredit 8,872.38 48 5.38%
3 BNP Paribas 8,684.90 48 5.27%
4 Deutsche Bank 8,298.69 30 5.04%
5 Commerzbank Group 8,007.20 41 4.86%

Bookrunners of all EMEA ECM Issuance

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • Today
1 Morgan Stanley 4,430.39 19 11.07%
2 Goldman Sachs 4,006.06 15 10.01%
3 Citi 3,572.77 22 8.93%
4 JPMorgan 2,809.08 19 7.02%
5 UBS 2,281.21 12 5.70%